140 results
424B3
CRVO
CervoMed Inc
6 Jun 24
Prospectus supplement
6:03am
NOLs could expire or otherwise be unavailable to offset future income tax liabilities.
The Company incurs costs and demands upon management … in taxable years beginning after December 31, 2017 may offset no more than 80 percent of such year’s taxable income and there is no ability for such NOLs
8-K/A
EX-99.2
pqjv04d4
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.1
l6e xg6eqnv7302q
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
425
EX-99.2
mfg51q5a 4nhtx1p
9 Aug 23
Business combination disclosure
4:02pm
8-K
EX-99.2
8fnh8p
9 Aug 23
Other Events
4:02pm
424B3
pr0ol
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
39yweyp 84j8ush1foie
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
EX-10.23
m70rx6jo3i2thup
10 May 23
Registration of securities issued in business combination transactions
9:56pm
S-4
yjujb
10 May 23
Registration of securities issued in business combination transactions
9:56pm
8-K
EX-99.1
kzen dy1b4
16 Aug 22
Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
4:21pm